Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
SEC Accession No. 0001641172-25-024152
Filing Date
2025-08-14
Accepted
2025-08-14 17:01:51
Documents
1
Period of Report
2025-06-30
Effectiveness Date
2025-08-14

Document Format Files

Seq Description Document Type Size
1 NT 10-Q formnt10-q.htm NT 10-Q 33311
  Complete submission text file 0001641172-25-024152.txt   34740
Mailing Address 1185 AVENUE OF THE AMERICAS SUITE 249 NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS SUITE 249 NEW YORK NY 10036 856-848-8698
TNF Pharmaceuticals, Inc. (Filer) CIK: 0001321834 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: NT 10-Q | Act: 34 | File No.: 001-36268 | Film No.: 251220728
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)